540 related articles for article (PubMed ID: 20842026)
1. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
Yki-Järvinen H
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
[TBL] [Abstract][Full Text] [Related]
2. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
[TBL] [Abstract][Full Text] [Related]
3. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
4. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
Lê KA; Bortolotti M
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
[TBL] [Abstract][Full Text] [Related]
5. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
8. Role of diet and nutritional management in non-alcoholic fatty liver disease.
Fan JG; Cao HX
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
[TBL] [Abstract][Full Text] [Related]
9. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
[TBL] [Abstract][Full Text] [Related]
10. Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease.
Schultz A; Mendonca LS; Aguila MB; Mandarim-de-Lacerda CA
Exp Toxicol Pathol; 2012 May; 64(4):273-82. PubMed ID: 20869214
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
12. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
[TBL] [Abstract][Full Text] [Related]
13. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis and the metabolic syndrome.
Jiang J; Torok N
Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
17. Dietary fructose in nonalcoholic fatty liver disease.
Vos MB; Lavine JE
Hepatology; 2013 Jun; 57(6):2525-31. PubMed ID: 23390127
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
19. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
20. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease.
Spruss A; Bergheim I
J Nutr Biochem; 2009 Sep; 20(9):657-62. PubMed ID: 19679262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]